Clinical Benefits Promotes delta wave activity and deep sleep stages where the most restorative physiological processes occur including physical recovery, immune optimization, and metabolic regulation
Both peptides demonstrate excellent safety profiles in available research
Yet, it became clear quite quickly that severe cases of COVID-19 comprise systemic endothelial dysfunction and inflammation in respiratory and non-respiratory organs that result from deregulated type I interferon (IFN I) signalling ( Several studies identified DNA-sensing pattern recognition receptors (PRRs) as drivers of IFN I-driven inflammation and massive cell death in severe COVID-19: cyclic GMPAMP synthase (cGAS), absent in melanoma (AIM)2, nucleotide-binding oligomerization domain (NOD)-like leucine-rich repeat (LRR) and PYRIN domain containing (NLRP)3, receptor for advanced glycation end products (RAGE), and Toll-like receptor (TLR)9 ( Figure 1 , see refs ( Figure 1 8 ] activating IRF3
Skin Health Support Helps with overall skin health when used under medical supervision
BPC-157 may also be effective in treating patients with traumatic brain injuries (TBI) and concussion
Phase 2 trials provide absorption, distribution, and adverse event profiles across 300+ participants with 12-week exposure timelines